Corporate | 31 October 2011 13:33
|
STADA Arzneimittel AG / Key word(s): Miscellaneous
Corporate News STADA sales companies very successful in tenders for discount agreements with various German public health insurance organizations Bad Vilbel, October 31, 2011 – In the view of the Executive Board, the STADA sales companies STADApharm GmbH, ALIUD PHARMA GmbH and cell pharm Gesellschaft für pharmazeutische und diagnostische Präparate mbH were very successful in the last round of tenders with KKH-Allianz, Vereinigten IKK and the Techniker Krankenkasse (TK) for discount agreements pursuant to Section 130 a SGB V valid throughout Germany. The three STADA sales companies thus received contracts for 76 active ingredients from a total of 200 active ingredients – including some product launches and in-house production – in the tender rounds KKH 4, IKK 2 and TK 3. The contracts are legally effective, take effect on January 01, 2012 and February 01, 2012 and have a regular term of two years. Depending on the design of the contract, the relevant STADA sales company is either the exclusive contract partner or one of three contract partners of the respective public health insurance organizations. In view of these newly concluded discount agreements and the in part large-volume awards previously received from other public health insurance organizations, STADA’s Executive Board expects that the Group’s market share by volume in the German market will increase further. Overall, STADA now has discount agreements with almost all public health insurance organizations in Germany.
Additional information:
End of Corporate News 31.10.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
| Language: | English | |
| Company: | STADA Arzneimittel AG | |
| Stadastraße 2-18 | ||
| 61118 Bad Vilbel | ||
| Germany | ||
| Phone: | +49 (0)6101 603- 113 | |
| Fax: | +49 (0)6101 603- 506 | |
| E-mail: | communications@stada.de | |
| Internet: | www.stada.de | |
| ISIN: | DE0007251803, DE0007251845, | |
| WKN: | 725180, 725184, | |
| Listed: | Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard); Freiverkehr in Berlin, Hamburg, Hannover, München, Stuttgart | |
| End of News | DGAP News-Service |
|
|
| 144124 31.10.2011 |